Gary D. Tollefson, M.D., Ph.D.

Original Research

Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance

October 14, 2005

Richard C. Shelton, Douglas J. Williamson, Sara A. Corya, et al

Original Research

Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years

September 15, 2003

Peter D. Feldman, Christopher J. Kaiser, John S. Kennedy, et al

Original Research

Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone

April 1, 2001

Bruce R. Basson, Bruce J. Kinon, Cindy C. Taylor, et al

Original Research

Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia

February 2, 2001

Bruce J. Kinon, Bruce R. Basson, Julie A. Gilmore, et al

Article

Evidence for the Effectiveness of Olanzapine Among Patients Nonresponsive and/or Intolerant to Risperidone

February 1, 2001

Petra Kratky, Michael Schneidman, Starr L. Grundy, et al

Article

Should We Consider Mood Disturbance in Schizophrenia as an Important Determinant of Quality of Life?

May 1, 1999

Gary D. Tollefson, Scott W. Andersen

Article

Concluding Remarks

December 1, 1997

Gary D. Tollefson

Original Research

Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia

May 15, 1997

Pierre V. Tran, Mary Anne Dellva, Gary D. Tollefson, et al

Article

Safety of Olanzapine

March 1, 1997

Charles M. Beasley, Jr., Gary D. Tollefson, Pierre V. Tran

Article

Efficacy of Olanzapine: An Overview of Pivotal Clinical Trials

February 1, 1997

Charles M. Beasley, Jr., Gary D. Tollefson, Pierre V. Tran

Gary D. Tollefson, M.D., Ph.D.

Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance

Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years

Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone

Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia

Evidence for the Effectiveness of Olanzapine Among Patients Nonresponsive and/or Intolerant to Risperidone

Should We Consider Mood Disturbance in Schizophrenia as an Important Determinant of Quality of Life?

Concluding Remarks

Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia

Safety of Olanzapine

Efficacy of Olanzapine: An Overview of Pivotal Clinical Trials

ELSEWHERE:

FOLLOW US:

Gary D. Tollefson, M.D., Ph.D.

Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance

Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years

Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone

Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia

Evidence for the Effectiveness of Olanzapine Among Patients Nonresponsive and/or Intolerant to Risperidone

Should We Consider Mood Disturbance in Schizophrenia as an Important Determinant of Quality of Life?

Concluding Remarks

Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia

Safety of Olanzapine

Efficacy of Olanzapine: An Overview of Pivotal Clinical Trials

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles